B Capital buys 2% stake in pharma marketplace PharmEasy from Everstone for $20-M: report
B Capital has picked up an around 2% stake in Mumbai-based online pharmacy PharmEasy for USD 20 million through a secondary deal, buying shares from Everstone Capital, which has made a part-exit. US-based investment firm Tiger Global is also finalising a USD 20 million primary capital infusion in PharmEasy's parent API Holdings. PharmEasy is also conducting a USD 3 million buyback of ESOPs in what would be its second such move in about three months.
From the Venture Intelligence PE-VC Deal Database: Between Jan-16 and Apr-21, PharmEasy had raised over $888-M from Think Investments, Prosus Ventures, LGT Lightstone Aspada, TPG Capital, CDPQ, Eight Roads Ventures, Temasek, Bessemer, Orios VP, Fundamentum, Eight Roads Ventures, KB Investment, Trifecta Capital, Aarin Capital, JM Financial, Astarc Ventures and others.
Want to receive such news items in your inbox? Click Here to sign up for a trial.